To further verify the impact of ADAMTS8 on the target therapies of EGFR-mutant lung cancer, we assessed the levels of ADAMTS8 in several LUAD cell lines with mutated EGFR based on the sensitivity of TKI treatment. Here, EGFR is linked to lung carcinoma.